| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |